Trial Profile
An International study investigating sirolimus eluting stent Xposition S in Challenging Lesions with Vessel Diameter Variance: SIZING Registry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2018
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 31 Oct 2018 New trial record
- 25 Sep 2018 Subgroup analysis will be presented at TCT 2018, as reported in an abstract presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
- 25 Sep 2018 Results from Dutch population (n=203) presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics